The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Lesinurad, also known as RDEA594, is a selective uric acid re-absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body.
The global Lesinurad market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lesinurad is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lesinurad is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Lesinurad include AbMole BioScience, Ausun Pharmaceutical, Cayman Chemical, MedKoo Biosciences, Clearsynth, Target Mol, UQUIFA, MSN Labs and CHEMO, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lesinurad, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lesinurad.
The Lesinurad market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lesinurad market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lesinurad manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AbMole BioScience
Ausun Pharmaceutical
Cayman Chemical
MedKoo Biosciences
Clearsynth
Target Mol
UQUIFA
MSN Labs
CHEMO
Nifty Labs
Manus Aktteva Biopharma LLP
Vcare Pharmatech
Meso Chem
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Research Institute
Pharmaceutical
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lesinurad manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lesinurad by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lesinurad in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Lesinurad, also known as RDEA594, is a selective uric acid re-absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body.
The global Lesinurad market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lesinurad is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lesinurad is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Lesinurad include AbMole BioScience, Ausun Pharmaceutical, Cayman Chemical, MedKoo Biosciences, Clearsynth, Target Mol, UQUIFA, MSN Labs and CHEMO, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lesinurad, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lesinurad.
The Lesinurad market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lesinurad market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lesinurad manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AbMole BioScience
Ausun Pharmaceutical
Cayman Chemical
MedKoo Biosciences
Clearsynth
Target Mol
UQUIFA
MSN Labs
CHEMO
Nifty Labs
Manus Aktteva Biopharma LLP
Vcare Pharmatech
Meso Chem
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Research Institute
Pharmaceutical
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lesinurad manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lesinurad by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lesinurad in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Lesinurad Market Overview
1.1 Product Definition
1.2 Lesinurad Segment by Type
1.2.1 Global Lesinurad Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Lesinurad Segment by Application
1.3.1 Global Lesinurad Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Research Institute
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Lesinurad Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Lesinurad Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Lesinurad Production Estimates and Forecasts (2018-2029)
1.4.4 Global Lesinurad Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lesinurad Production Market Share by Manufacturers (2018-2023)
2.2 Global Lesinurad Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Lesinurad, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Lesinurad Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Lesinurad Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Lesinurad, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lesinurad, Product Offered and Application
2.8 Global Key Manufacturers of Lesinurad, Date of Enter into This Industry
2.9 Lesinurad Market Competitive Situation and Trends
2.9.1 Lesinurad Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lesinurad Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lesinurad Production by Region
3.1 Global Lesinurad Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Lesinurad Production Value by Region (2018-2029)
3.2.1 Global Lesinurad Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Lesinurad by Region (2024-2029)
3.3 Global Lesinurad Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Lesinurad Production by Region (2018-2029)
3.4.1 Global Lesinurad Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Lesinurad by Region (2024-2029)
3.5 Global Lesinurad Market Price Analysis by Region (2018-2023)
3.6 Global Lesinurad Production and Value, Year-over-Year Growth
3.6.1 North America Lesinurad Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Lesinurad Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Lesinurad Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Lesinurad Production Value Estimates and Forecasts (2018-2029)
4 Lesinurad Consumption by Region
4.1 Global Lesinurad Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Lesinurad Consumption by Region (2018-2029)
4.2.1 Global Lesinurad Consumption by Region (2018-2023)
4.2.2 Global Lesinurad Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Lesinurad Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Lesinurad Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lesinurad Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Lesinurad Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lesinurad Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Lesinurad Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lesinurad Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Lesinurad Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Lesinurad Production by Type (2018-2029)
5.1.1 Global Lesinurad Production by Type (2018-2023)
5.1.2 Global Lesinurad Production by Type (2024-2029)
5.1.3 Global Lesinurad Production Market Share by Type (2018-2029)
5.2 Global Lesinurad Production Value by Type (2018-2029)
5.2.1 Global Lesinurad Production Value by Type (2018-2023)
5.2.2 Global Lesinurad Production Value by Type (2024-2029)
5.2.3 Global Lesinurad Production Value Market Share by Type (2018-2029)
5.3 Global Lesinurad Price by Type (2018-2029)
6 Segment by Application
6.1 Global Lesinurad Production by Application (2018-2029)
6.1.1 Global Lesinurad Production by Application (2018-2023)
6.1.2 Global Lesinurad Production by Application (2024-2029)
6.1.3 Global Lesinurad Production Market Share by Application (2018-2029)
6.2 Global Lesinurad Production Value by Application (2018-2029)
6.2.1 Global Lesinurad Production Value by Application (2018-2023)
6.2.2 Global Lesinurad Production Value by Application (2024-2029)
6.2.3 Global Lesinurad Production Value Market Share by Application (2018-2029)
6.3 Global Lesinurad Price by Application (2018-2029)
7 Key Companies Profiled
7.1 AbMole BioScience
7.1.1 AbMole BioScience Lesinurad Corporation Information
7.1.2 AbMole BioScience Lesinurad Product Portfolio
7.1.3 AbMole BioScience Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.1.4 AbMole BioScience Main Business and Markets Served
7.1.5 AbMole BioScience Recent Developments/Updates
7.2 Ausun Pharmaceutical
7.2.1 Ausun Pharmaceutical Lesinurad Corporation Information
7.2.2 Ausun Pharmaceutical Lesinurad Product Portfolio
7.2.3 Ausun Pharmaceutical Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Ausun Pharmaceutical Main Business and Markets Served
7.2.5 Ausun Pharmaceutical Recent Developments/Updates
7.3 Cayman Chemical
7.3.1 Cayman Chemical Lesinurad Corporation Information
7.3.2 Cayman Chemical Lesinurad Product Portfolio
7.3.3 Cayman Chemical Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Cayman Chemical Main Business and Markets Served
7.3.5 Cayman Chemical Recent Developments/Updates
7.4 MedKoo Biosciences
7.4.1 MedKoo Biosciences Lesinurad Corporation Information
7.4.2 MedKoo Biosciences Lesinurad Product Portfolio
7.4.3 MedKoo Biosciences Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.4.4 MedKoo Biosciences Main Business and Markets Served
7.4.5 MedKoo Biosciences Recent Developments/Updates
7.5 Clearsynth
7.5.1 Clearsynth Lesinurad Corporation Information
7.5.2 Clearsynth Lesinurad Product Portfolio
7.5.3 Clearsynth Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Clearsynth Main Business and Markets Served
7.5.5 Clearsynth Recent Developments/Updates
7.6 Target Mol
7.6.1 Target Mol Lesinurad Corporation Information
7.6.2 Target Mol Lesinurad Product Portfolio
7.6.3 Target Mol Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Target Mol Main Business and Markets Served
7.6.5 Target Mol Recent Developments/Updates
7.7 UQUIFA
7.7.1 UQUIFA Lesinurad Corporation Information
7.7.2 UQUIFA Lesinurad Product Portfolio
7.7.3 UQUIFA Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.7.4 UQUIFA Main Business and Markets Served
7.7.5 UQUIFA Recent Developments/Updates
7.8 MSN Labs
7.8.1 MSN Labs Lesinurad Corporation Information
7.8.2 MSN Labs Lesinurad Product Portfolio
7.8.3 MSN Labs Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.8.4 MSN Labs Main Business and Markets Served
7.7.5 MSN Labs Recent Developments/Updates
7.9 CHEMO
7.9.1 CHEMO Lesinurad Corporation Information
7.9.2 CHEMO Lesinurad Product Portfolio
7.9.3 CHEMO Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.9.4 CHEMO Main Business and Markets Served
7.9.5 CHEMO Recent Developments/Updates
7.10 Nifty Labs
7.10.1 Nifty Labs Lesinurad Corporation Information
7.10.2 Nifty Labs Lesinurad Product Portfolio
7.10.3 Nifty Labs Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Nifty Labs Main Business and Markets Served
7.10.5 Nifty Labs Recent Developments/Updates
7.11 Manus Aktteva Biopharma LLP
7.11.1 Manus Aktteva Biopharma LLP Lesinurad Corporation Information
7.11.2 Manus Aktteva Biopharma LLP Lesinurad Product Portfolio
7.11.3 Manus Aktteva Biopharma LLP Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Manus Aktteva Biopharma LLP Main Business and Markets Served
7.11.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
7.12 Vcare Pharmatech
7.12.1 Vcare Pharmatech Lesinurad Corporation Information
7.12.2 Vcare Pharmatech Lesinurad Product Portfolio
7.12.3 Vcare Pharmatech Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Vcare Pharmatech Main Business and Markets Served
7.12.5 Vcare Pharmatech Recent Developments/Updates
7.13 Meso Chem
7.13.1 Meso Chem Lesinurad Corporation Information
7.13.2 Meso Chem Lesinurad Product Portfolio
7.13.3 Meso Chem Lesinurad Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Meso Chem Main Business and Markets Served
7.13.5 Meso Chem Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lesinurad Industry Chain Analysis
8.2 Lesinurad Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lesinurad Production Mode & Process
8.4 Lesinurad Sales and Marketing
8.4.1 Lesinurad Sales Channels
8.4.2 Lesinurad Distributors
8.5 Lesinurad Customers
9 Lesinurad Market Dynamics
9.1 Lesinurad Industry Trends
9.2 Lesinurad Market Drivers
9.3 Lesinurad Market Challenges
9.4 Lesinurad Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Lesinurad Market Value by Type, (US$ Million) & (2022 VS 2029)
Table 2. Global Lesinurad Market Value by Application, (US$ Million) & (2022 VS 2029)
Table 3. Global Lesinurad Production Capacity (Tons) by Manufacturers in 2022
Table 4. Global Lesinurad Production by Manufacturers (2018-2023) & (Tons)
Table 5. Global Lesinurad Production Market Share by Manufacturers (2018-2023)
Table 6. Global Lesinurad Production Value by Manufacturers (2018-2023) & (US$ Million)
Table 7. Global Lesinurad Production Value Share by Manufacturers (2018-2023)
Table 8. Global Lesinurad Industry Ranking 2021 VS 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lesinurad as of 2022)
Table 10. Global Market Lesinurad Average Price by Manufacturers (US$/Ton) & (2018-2023)
Table 11. Manufacturers Lesinurad Production Sites and Area Served
Table 12. Manufacturers Lesinurad Product Types
Table 13. Global Lesinurad Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Lesinurad Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Lesinurad Production Value (US$ Million) by Region (2018-2023)
Table 17. Global Lesinurad Production Value Market Share by Region (2018-2023)
Table 18. Global Lesinurad Production Value (US$ Million) Forecast by Region (2024-2029)
Table 19. Global Lesinurad Production Value Market Share Forecast by Region (2024-2029)
Table 20. Global Lesinurad Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)
Table 21. Global Lesinurad Production (Tons) by Region (2018-2023)
Table 22. Global Lesinurad Production Market Share by Region (2018-2023)
Table 23. Global Lesinurad Production (Tons) Forecast by Region (2024-2029)
Table 24. Global Lesinurad Production Market Share Forecast by Region (2024-2029)
Table 25. Global Lesinurad Market Average Price (US$/Ton) by Region (2018-2023)
Table 26. Global Lesinurad Market Average Price (US$/Ton) by Region (2024-2029)
Table 27. Global Lesinurad Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)
Table 28. Global Lesinurad Consumption by Region (2018-2023) & (Tons)
Table 29. Global Lesinurad Consumption Market Share by Region (2018-2023)
Table 30. Global Lesinurad Forecasted Consumption by Region (2024-2029) & (Tons)
Table 31. Global Lesinurad Forecasted Consumption Market Share by Region (2018-2023)
Table 32. North America Lesinurad Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
Table 33. North America Lesinurad Consumption by Country (2018-2023) & (Tons)
Table 34. North America Lesinurad Consumption by Country (2024-2029) & (Tons)
Table 35. Europe Lesinurad Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
Table 36. Europe Lesinurad Consumption by Country (2018-2023) & (Tons)
Table 37. Europe Lesinurad Consumption by Country (2024-2029) & (Tons)
Table 38. Asia Pacific Lesinurad Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (Tons)
Table 39. Asia Pacific Lesinurad Consumption by Region (2018-2023) & (Tons)
Table 40. Asia Pacific Lesinurad Consumption by Region (2024-2029) & (Tons)
Table 41. Latin America, Middle East & Africa Lesinurad Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Tons)
Table 42. Latin America, Middle East & Africa Lesinurad Consumption by Country (2018-2023) & (Tons)
Table 43. Latin America, Middle East & Africa Lesinurad Consumption by Country (2024-2029) & (Tons)
Table 44. Global Lesinurad Production (Tons) by Type (2018-2023)
Table 45. Global Lesinurad Production (Tons) by Type (2024-2029)
Table 46. Global Lesinurad Production Market Share by Type (2018-2023)
Table 47. Global Lesinurad Production Market Share by Type (2024-2029)
Table 48. Global Lesinurad Production Value (US$ Million) by Type (2018-2023)
Table 49. Global Lesinurad Production Value (US$ Million) by Type (2024-2029)
Table 50. Global Lesinurad Production Value Share by Type (2018-2023)
Table 51. Global Lesinurad Production Value Share by Type (2024-2029)
Table 52. Global Lesinurad Price (US$/Ton) by Type (2018-2023)
Table 53. Global Lesinurad Price (US$/Ton) by Type (2024-2029)
Table 54. Global Lesinurad Production (Tons) by Application (2018-2023)
Table 55. Global Lesinurad Production (Tons) by Application (2024-2029)
Table 56. Global Lesinurad Production Market Share by Application (2018-2023)
Table 57. Global Lesinurad Production Market Share by Application (2024-2029)
Table 58. Global Lesinurad Production Value (US$ Million) by Application (2018-2023)
Table 59. Global Lesinurad Production Value (US$ Million) by Application (2024-2029)
Table 60. Global Lesinurad Production Value Share by Application (2018-2023)
Table 61. Global Lesinurad Production Value Share by Application (2024-2029)
Table 62. Global Lesinurad Price (US$/Ton) by Application (2018-2023)
Table 63. Global Lesinurad Price (US$/Ton) by Application (2024-2029)
Table 64. AbMole BioScience Lesinurad Corporation Information
Table 65. AbMole BioScience Specification and Application
Table 66. AbMole BioScience Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 67. AbMole BioScience Main Business and Markets Served
Table 68. AbMole BioScience Recent Developments/Updates
Table 69. Ausun Pharmaceutical Lesinurad Corporation Information
Table 70. Ausun Pharmaceutical Specification and Application
Table 71. Ausun Pharmaceutical Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 72. Ausun Pharmaceutical Main Business and Markets Served
Table 73. Ausun Pharmaceutical Recent Developments/Updates
Table 74. Cayman Chemical Lesinurad Corporation Information
Table 75. Cayman Chemical Specification and Application
Table 76. Cayman Chemical Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 77. Cayman Chemical Main Business and Markets Served
Table 78. Cayman Chemical Recent Developments/Updates
Table 79. MedKoo Biosciences Lesinurad Corporation Information
Table 80. MedKoo Biosciences Specification and Application
Table 81. MedKoo Biosciences Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. MedKoo Biosciences Main Business and Markets Served
Table 83. MedKoo Biosciences Recent Developments/Updates
Table 84. Clearsynth Lesinurad Corporation Information
Table 85. Clearsynth Specification and Application
Table 86. Clearsynth Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Clearsynth Main Business and Markets Served
Table 88. Clearsynth Recent Developments/Updates
Table 89. Target Mol Lesinurad Corporation Information
Table 90. Target Mol Specification and Application
Table 91. Target Mol Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Target Mol Main Business and Markets Served
Table 93. Target Mol Recent Developments/Updates
Table 94. UQUIFA Lesinurad Corporation Information
Table 95. UQUIFA Specification and Application
Table 96. UQUIFA Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. UQUIFA Main Business and Markets Served
Table 98. UQUIFA Recent Developments/Updates
Table 99. MSN Labs Lesinurad Corporation Information
Table 100. MSN Labs Specification and Application
Table 101. MSN Labs Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. MSN Labs Main Business and Markets Served
Table 103. MSN Labs Recent Developments/Updates
Table 104. CHEMO Lesinurad Corporation Information
Table 105. CHEMO Specification and Application
Table 106. CHEMO Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. CHEMO Main Business and Markets Served
Table 108. CHEMO Recent Developments/Updates
Table 109. Nifty Labs Lesinurad Corporation Information
Table 110. Nifty Labs Specification and Application
Table 111. Nifty Labs Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Nifty Labs Main Business and Markets Served
Table 113. Nifty Labs Recent Developments/Updates
Table 114. Manus Aktteva Biopharma LLP Lesinurad Corporation Information
Table 115. Manus Aktteva Biopharma LLP Specification and Application
Table 116. Manus Aktteva Biopharma LLP Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Manus Aktteva Biopharma LLP Main Business and Markets Served
Table 118. Manus Aktteva Biopharma LLP Recent Developments/Updates
Table 119. Vcare Pharmatech Lesinurad Corporation Information
Table 120. Vcare Pharmatech Specification and Application
Table 121. Vcare Pharmatech Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Vcare Pharmatech Main Business and Markets Served
Table 123. Vcare Pharmatech Recent Developments/Updates
Table 124. Meso Chem Lesinurad Corporation Information
Table 125. Meso Chem Specification and Application
Table 126. Meso Chem Lesinurad Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Meso Chem Main Business and Markets Served
Table 128. Meso Chem Recent Developments/Updates
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Lesinurad Distributors List
Table 132. Lesinurad Customers List
Table 133. Lesinurad Market Trends
Table 134. Lesinurad Market Drivers
Table 135. Lesinurad Market Challenges
Table 136. Lesinurad Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lesinurad
Figure 2. Global Lesinurad Market Value by Type, (US$ Million) & (2022 VS 2029)
Figure 3. Global Lesinurad Market Share by Type: 2022 VS 2029
Figure 4. Purity ≥ 98 % Product Picture
Figure 5. Purity ≥ 99 % Product Picture
Figure 6. Global Lesinurad Market Value by Application, (US$ Million) & (2022 VS 2029)
Figure 7. Global Lesinurad Market Share by Application: 2022 VS 2029
Figure 8. Research Institute
Figure 9. Pharmaceutical
Figure 10. Others
Figure 11. Global Lesinurad Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Lesinurad Production Value (US$ Million) & (2018-2029)
Figure 13. Global Lesinurad Production Capacity (Tons) & (2018-2029)
Figure 14. Global Lesinurad Production (Tons) & (2018-2029)
Figure 15. Global Lesinurad Average Price (US$/Ton) & (2018-2029)
Figure 16. Lesinurad Report Years Considered
Figure 17. Lesinurad Production Share by Manufacturers in 2022
Figure 18. Lesinurad Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. The Global 5 and 10 Largest Players: Market Share by Lesinurad Revenue in 2022
Figure 20. Global Lesinurad Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 21. Global Lesinurad Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 22. Global Lesinurad Production Comparison by Region: 2018 VS 2022 VS 2029 (Tons)
Figure 23. Global Lesinurad Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 24. North America Lesinurad Production Value (US$ Million) Growth Rate (2018-2029)
Figure 25. Europe Lesinurad Production Value (US$ Million) Growth Rate (2018-2029)
Figure 26. China Lesinurad Production Value (US$ Million) Growth Rate (2018-2029)
Figure 27. Japan Lesinurad Production Value (US$ Million) Growth Rate (2018-2029)
Figure 28. Global Lesinurad Consumption by Region: 2018 VS 2022 VS 2029 (Tons)
Figure 29. Global Lesinurad Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 30. North America Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 31. North America Lesinurad Consumption Market Share by Country (2018-2029)
Figure 32. Canada Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 33. U.S. Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 34. Europe Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 35. Europe Lesinurad Consumption Market Share by Country (2018-2029)
Figure 36. Germany Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 37. France Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 38. U.K. Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 39. Italy Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 40. Russia Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 41. Asia Pacific Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 42. Asia Pacific Lesinurad Consumption Market Share by Regions (2018-2029)
Figure 43. China Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 44. Japan Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 45. South Korea Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 46. China Taiwan Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 47. Southeast Asia Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 48. India Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 49. Latin America, Middle East & Africa Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 50. Latin America, Middle East & Africa Lesinurad Consumption Market Share by Country (2018-2029)
Figure 51. Mexico Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 52. Brazil Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 53. Turkey Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 54. GCC Countries Lesinurad Consumption and Growth Rate (2018-2023) & (Tons)
Figure 55. Global Production Market Share of Lesinurad by Type (2018-2029)
Figure 56. Global Production Value Market Share of Lesinurad by Type (2018-2029)
Figure 57. Global Lesinurad Price (US$/Ton) by Type (2018-2029)
Figure 58. Global Production Market Share of Lesinurad by Application (2018-2029)
Figure 59. Global Production Value Market Share of Lesinurad by Application (2018-2029)
Figure 60. Global Lesinurad Price (US$/Ton) by Application (2018-2029)
Figure 61. Lesinurad Value Chain
Figure 62. Lesinurad Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
